Otolaryngology Doctors in St Louis, MO Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

John A Stith, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista, St Louis, MO 63110 Phone: 314-577-8887    Fax: 314-268-5111

Emily E Ziaee, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10004 Kennerly Rd, Sle 183b, St Louis, MO 63128 Phone: 314-843-8400    Fax: 314-843-8402

Thomas J Donovan, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3660 Vista, St Louis, MO 63110 Phone: 314-577-8887    Fax: 314-268-5111

Philip L Martin, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 11144 Tesson Ferry Rd, #205, St Louis, MO 63123 Phone: 314-842-8427    Fax: 314-842-8262

Jose A Lima, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10004 Kennerly Rd, Ste 183b, St Louis, MO 63128 Phone: 314-843-8400    Fax: 314-840-8402

Dr. Allison Slijepcevic, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Barnes-jewish Hospital Plaza, Barnes-jewish Hospital, St Louis, MO 63110 Phone: 314-362-5000

Dr. Chan P Vo, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2900 Lemay Ferry Rd, Suite #226, St Louis, MO 63125 Phone: 314-894-9192    Fax: 314-894-3210

Michael J Odell, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3660 Vista, St Louis, MO 63110 Phone: 314-577-8887    Fax: 314-268-5111

Steven E. West, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10004 Kennerly Rd, Sle 183b, St Louis, MO 63128 Phone: 314-843-8400    Fax: 314-843-8402

News Archive

Oxygen Biotherapeutics submits a patent application for its heart attack treatment device

Oxygen Biotherapeutics, Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte(R) perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

Study compares long-term metabolic effects of conventional and genetically-modified soybean oil

Researchers at the University of California, Riverside have tested a genetically-modified (GM) soybean oil used in restaurants and found that while it induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil.

FDA revokes approval of Avastin for breast cancer

The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials.

Kaiser Permanente honored as the fifth Most Innovative Health Care Company for pioneering EHR

Kaiser Permanente has been honored in Fast Company's annual Most Innovative Companies issue as the fifth Most Innovative Health Care Company in the World for its pioneering electronic health record that is the world's largest civilian electronic health record, and for its health care innovation center that develops the future of health care.

Read more Medical News

› Verified 1 days ago